Skip to content
S7839Senate2023-2024 SessionSame asA8596

Let Pharmacists Treat Common Illnesses

Official title

“Relates to the definition of practice of pharmacy”

Sponsor Gustavo RiveraSD-33+8 co-sponsorsAffects Education
Status
In Senate Committee
Higher Education
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Higher Education

What's happening

This bill allows pharmacists to initiate treatment for COVID-19, influenza, and strep throat under state health protocols until April 2026.

Why it matters

  1. Expands timely access to treatment. By allowing pharmacists to initiate treatment for COVID-19, flu, and strep throat after a positive test, the bill could help people get care faster, particularly during outbreaks or when doctor appointments are hard to secure.

  2. Protects patient safety and continuity of care. The bill requires pharmacists to follow strict statewide protocols, including patient safety measures, record-keeping, and mandatory reporting of treatments to patients’ primary care providers (with patient consent), helping to integrate pharmacy-initiated care into broader healthcare management.

  3. Strengthens primary care connections. Pharmacists must ask patients if they have a regular healthcare provider and offer lists of local, accessible primary care options—especially for those without one—potentially increasing the number of patients who establish ongoing primary care relationships.

  4. Prioritizes equity and accessibility. The Department of Health’s provider lists must highlight clinics serving Medicaid, low-income, uninsured, and disabled populations, and indicate providers’ cultural and language capabilities, aiming to reduce barriers for underserved groups.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Let Pharmacists Treat Common Illnesses

Plain English, a few words. Used as the page title.

Sponsors

History

  1. Referred to higher education
  2. Referred to rules

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A8596Assembly

Let Pharmacists Treat Flu

In Assembly Committee · Higher Education · Sponsor John T. McDonald III

Impact 7 · Significant0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

7839

2023-2024 Regular Sessions

IN SENATE

December 27, 2023

Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Rules

AN ACT to amend the education law, in relation to the definition of practice of pharmacy; and providing for the repeal of such provisions upon expiration thereof

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 6801 of the education law is amended by adding a new subdivision 7-a to read as follows:

7-a. (a) A licensed pharmacist may initiate treatment for COVID-19, influenza, and pharyngitis resulting from a Group A streptococcal infection upon a positive test result conducted pursuant to subdivision seven of this section. Such treatment shall be provided pursuant to a statewide protocol developed by the department of health. Such protocol shall address issues including but not limited to patient safety, record keeping, referral for treatment and continuity of care, case reporting to the patient's primary care or other health care providers. The protocol shall also include procedures for appropriate referrals for any patient that requires additional treatment or experiences an adverse reaction to the treatment authorized pursuant to this subdivision.

(b) A pharmacist initiating treatment under this protocol shall at a minimum: (i) inquire of each patient whether he or she has a primary care provider or other health care provider that the patient regularly sees; and (ii) maintain and regularly update a list of local primary care providers including those located in the applicable zip code area and adjacent zip code areas of the pharmacy. This list shall be provided to each patient who indicates that he or she does not have a primary care provider.

(c) The department of health shall produce, maintain, and periodically update a list of primary care providers on its website, in searchable form that shall include relevant zip codes of the providers. The list

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD13878-01-3

developed by the department of health shall identify preferred providers who have achieved recognition as a patient centered medical home (PCMH) or other similar designation and a description of what such designation means. The list shall include federally qualified health centers and other providers who serve Medicaid, low-income and uninsured patients, and people with disabilities and shall identify cultural and linguistic capabilities when available.

(d) A pharmacist shall retain a record of the test result and treatment as part of the patient record and shall at a minimum provide a report of the test result and treatment to the patient's designated physician, physician's assistant or nurse practitioner, unless otherwise directed by the patient.

§ 2. This act shall take effect immediately and shall expire and be deemed repealed April 1, 2026.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the education law, in relation to the definition of practice of pharmacy; and providing for the repeal of such provisions upon expiration thereof

Purpose

The purpose of this bill is to authorize pharmacists to to begin treat- ment for common ailments pursuant to a protocol developed by the Commis- sioner of health, which will increase access to to care and reduce strains of the healthcare system.

Summary of provisions

Section 1 amends section 6801 of Education Law, by adding a new subdivi- sion 7-a to authorize a pharmacist to initiate treatment for COVID-19, influenza, and pharyngitis resulting from Group A streptococcal infection upon positive test result. This section would also direct the Commissioner of Health (COH) to develop a protocol for pharmacists providing this treatment. The protocol would at a minimum address patient safety, record keeping, referral for treatment and continuity of care, and case reporting to other healthcare professionals. This section would also establish responsibilities of a pharmacist conducting the treatment, which would include inquiring about and providing connections to local primary care services for the patient, as well as record keep- ing and reporting requirements.

Section 2 provides an effective date.

Justification

New York State is behind the rest of the country concerning the scope of practice for pharmacists and health care in general, especially when it comes to collaborative practice. According to the National Association of the Boards of Pharmacy, 39 states currently permit pharmacists to perform non-invasive FDA-approved tests, commonly described as Clinical Laboratory Improvement Amendments (CLIA)-waived tests. These are simple, low-risk tests available without a prescription or medical order.

Pharmacists are licensed clinicians uniquely situated to advance New York's public health objectives as they represent an opportunity to engage members of the public that otherwise might not be reached. Authorizing the Commissioner of Health to specify the tests that a phar- macist would perform limits the actual tests to be completed by' Ph'armacists and provides needed flexibility to respond to public health needs and programs.

This legislation can improve therapeutic outcomes and the quality of care overall. As mentioned, pharmacists are well-positioned to enhance the continuity of care connected to a patient's medical home.

Legislative history

New bill.

Fiscal implications

None.

Effective date

Effective immediately and shall expire to be deemed repealed April 1, 2026.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.